- Home
- CRNT vs RNA Comparison
CRNT vs RNA Comparison
Compare CRNT & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNT | RNA |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.1M | 199.7M |
| IPO Year | 2000 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CRNT | RNA |
|---|---|---|
| Price | $2.51 | $13.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 20 |
| Target Price | $3.50 | ★ $69.26 |
| AVG Volume (30 Days) | ★ 491.0K | 256.1K |
| Earning Date | 05-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.11 | $88.12 |
| Revenue Next Year | $6.70 | $18.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.82 | $11.95 |
| 52 Week High | $2.84 | $73.06 |
Technical Indicators
Market Signals| Indicator | CRNT | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | 35.16 |
| Support Level | $2.22 | $12.72 |
| Resistance Level | $2.61 | $14.80 |
| Average True Range (ATR) | 0.13 | 0.52 |
| MACD | -0.01 | 0.46 |
| Stochastic Oscillator | 28.74 | 43.08 |
Price Performance
Historical ComparisonAbout CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.